Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.6.3 was added to the record history, replacing the previous v3.6.2, indicating an update to the study record's metadata.SummaryDifference0.1%

- Check24 days agoChange DetectedA new revision entry (v3.6.2) was added to the study history and the earlier revision (v3.6.0) was removed, reflecting an update to the study record's version history.SummaryDifference0.1%

- Check38 days agoChange DetectedRecruitment status updated to not recruiting, reflecting that the study is no longer seeking participants; the study record revision was updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.4%

- Check45 days agoChange DetectedThe page history now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a platform update reflected on the page without altering study information.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a new revision entry v3.5.4 to the Study Record Versions, and removed the previous revision v3.5.3 from the history. This reflects an updated revision in the study's revision history.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov revision number (from v3.5.2 to v3.5.3). This represents an interface/version update rather than a change to the trial record history itself.SummaryDifference0.1%

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.